LRG1, which enriched in the MAPK pathway, has been strongly associated with worse overall survival for CRC, and may be considered as an independent prognostic indicator for CRC (Ladd et al., 2012; Zhang et al., 2016; Zhou et al., 2017; Zhang et al., 2018). This evidence concerns the gene LRG1 and colorectal carcinoma.